相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy
Hui-Ming Chen et al.
CLINICAL CANCER RESEARCH (2015)
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor et al.
NATURE (2015)
Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients
Maria Napolitano et al.
ONCOTARGET (2015)
Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy
Oana Draghiciu et al.
ONCOIMMUNOLOGY (2015)
Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice
Liufu Deng et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Increase in CD14+HLA-DR-/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis
Fumitaka Arihara et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated with Impaired T-Cell Functionality
Suresh Kalathil et al.
CANCER RESEARCH (2013)
Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma
Tamar Kapanadze et al.
JOURNAL OF HEPATOLOGY (2013)
Circulating and Tumor-Infiltrating Myeloid-Derived Suppressor Cells in Patients with Colorectal Carcinoma
Bin Zhang et al.
PLOS ONE (2013)
New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology
Stanley L. Liauw et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Myeloid derived suppressor cells: Targets for therapy
Todd J. Waldron et al.
ONCOIMMUNOLOGY (2013)
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Steffen Walter et al.
NATURE MEDICINE (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells
Samantha Solito et al.
BLOOD (2011)
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
Rachel F. Gabitass et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Myeloid derived suppressor cells in human diseases
Tim F. Greten et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Increased Circulating Immunosuppressive CD14+HLA-DR-/low Cells Correlate with Clinical Cancer Stage and Pathological Grade in Patients with Bladder Carcinoma
X-K Yuan et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2011)
Randomized, Phase II Study Comparing Interferon Combined with Hepatic Arterial Infusion of Fluorouracil plus Cisplatin and Fluorouracil Alone in Patients with Advanced Hepatocellular Carcinoma
Tatsuya Yamashita et al.
ONCOLOGY (2011)
Radiation Therapy for Hepatocellular Carcinoma
Mary Feng et al.
SEMINARS IN RADIATION ONCOLOGY (2011)
GENOMIC INSTABILITY IN CANCER Strategies to improve radiotherapy with targeted drugs
Adrian C. Begg et al.
NATURE REVIEWS CANCER (2011)
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity
Suzanne Ostrand-Rosenberg
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Immature Immunosuppressive CD14+HLA-DR-/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
Isabel Poschke et al.
CANCER RESEARCH (2010)
Treatment of Intermediate/Advanced Hepatocellular Carcinoma in the Clinic: How Can Outcomes Be Improved?
Riccardo Lencioni et al.
ONCOLOGIST (2010)
Immunosuppressive CD14+HLA-DRlow/- Monocytes in Prostate Cancer
Stanimir Vuk-Pavlovic et al.
PROSTATE (2010)
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells
Bastian Hoechst et al.
GASTROENTEROLOGY (2008)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Immunotherapeutic strategies for hepatocellular carcinoma
LH Butterfield
GASTROENTEROLOGY (2004)
Expansion of myeloid immune suppressor Gr+CD11b+cells in tumor-bearing host directly promotes tumor angiogenesis
L Yang et al.
CANCER CELL (2004)
L-arginine metabolism in myeloid cells controls T-lymphocyte functions
V Bronte et al.
TRENDS IN IMMUNOLOGY (2003)
Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation
Y Komorizono et al.
CANCER (2003)
Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis
SA Curley et al.
ANNALS OF SURGERY (2000)
分享论文
